Survival analysis of stage II gastric cancer patients after D2 gastrectomy: a Chinese people-based research
Abstract Objective The benefit of adjuvant chemotherapy is still controversial for stage II gastric cancer patients. This study aims to identify prognostic factors to guide individualized treatment for stage II gastric cancer patients. Methods We retrospectively reviewed 1121 stage II gastric cancer...
Main Authors: | Zi-Jian Deng, Run-Cong Nie, Jun Lu, Xi-Jie Chen, Jun Xiang, Chang-Ming Huang, Ying-Bo Chen, Jun-Sheng Peng, Shi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01937-9 |
Similar Items
-
Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis
by: Lili Wu, et al.
Published: (2021-09-01) -
Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis
by: Jian-Xian Lin, et al.
Published: (2019-02-01) -
Survival of stage II nasopharyngeal carcinoma patients with or without concurrent chemotherapy: A propensity score matching study
by: Di‐Han Liu, et al.
Published: (2020-02-01) -
Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
by: Daniel M. Girardi, et al.
Published: (2018-04-01) -
Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer
by: Ma GF, et al.
Published: (2019-07-01)